Published in World J Nephrol on May 06, 2016
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis (2002) 81.62
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension (2003) 63.78
Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med (2001) 20.18
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med (2009) 12.73
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med (2005) 12.72
Chronic kidney disease: global dimension and perspectives. Lancet (2013) 8.16
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest (2007) 6.56
Chronic kidney disease. Lancet (2011) 5.42
Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol (2010) 3.75
Early recognition and prevention of chronic kidney disease. Lancet (2010) 3.19
Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol (2008) 2.96
Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int (2004) 2.81
Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clin J Am Soc Nephrol (2010) 2.67
Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol (2010) 2.55
Health-related quality of life and estimates of utility in chronic kidney disease. Kidney Int (2005) 2.54
Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome. Nat Med (2013) 2.41
Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis (2009) 2.39
Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study. Lancet Diabetes Endocrinol (2015) 2.23
The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease. Kidney Int Suppl (2005) 2.10
The future burden of CKD in the United States: a simulation model for the CDC CKD Initiative. Am J Kidney Dis (2014) 2.06
NF-kappaB in renal inflammation. J Am Soc Nephrol (2010) 2.00
Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet (1982) 1.98
Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism. J Clin Endocrinol Metab (1988) 1.87
Association between protein intake and blood pressure: the INTERMAP Study. Arch Intern Med (2006) 1.79
The impact of protein intake on renal function decline in women with normal renal function or mild renal insufficiency. Ann Intern Med (2003) 1.71
Inflammation and the pathogenesis of diabetic nephropathy. Clin Sci (Lond) (2013) 1.69
Oxidative stress, anti-oxidant therapies and chronic kidney disease. Nephrology (Carlton) (2012) 1.61
Renal tubulointerstitial fibrosis: common but never simple. Am J Physiol Renal Physiol (2009) 1.60
Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group. J Am Soc Nephrol (1995) 1.58
Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction. J Am Soc Nephrol (2004) 1.55
Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney Int (2013) 1.52
Oxidative stress is progressively enhanced with advancing stages of CKD. Am J Kidney Dis (2006) 1.44
Dietary soya protein during pregnancy and lactation in rats with hereditary kidney disease attenuates disease progression in offspring. Br J Nutr (2007) 1.43
The influence of dietary protein source on longevity and age-related disease processes of Fischer rats. J Gerontol (1988) 1.43
Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial. Diabetes Care (2008) 1.41
TGF-β/Smad signaling in renal fibrosis. Front Physiol (2015) 1.36
Metabolism of dietary soy isoflavones to equol by human intestinal microflora--implications for health. Mol Nutr Food Res (2007) 1.28
Health-related quality of life in different stages of chronic kidney disease and at initiation of dialysis treatment. Health Qual Life Outcomes (2012) 1.22
Novel method for genomic analysis of PKD1 and PKD2 mutations in autosomal dominant polycystic kidney disease. Hum Mutat (2009) 1.20
Daidzein and genistein glucuronides in vitro are weakly estrogenic and activate human natural killer cells at nutritionally relevant concentrations. J Nutr (1999) 1.19
Diet and the suitability of the male Fischer 344 rat as a model for aging research. J Gerontol (1993) 1.18
Dietary modulation of the progression of nephropathy in aging rats: an evaluation of the importance of protein. Am J Clin Nutr (1989) 1.15
Cystic kidney disease: the role of Wnt signaling. Trends Mol Med (2010) 1.10
Oxidative stress, inflammation and cardiovascular disease in chronic renal failure. J Nephrol (2008) 1.10
Solvent extraction selection in the determination of isoflavones in soy foods. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 1.10
Diabetic kidney disease: from physiology to therapeutics. J Physiol (2014) 1.10
Soy-protein consumption and kidney-related biomarkers among type 2 diabetics: a crossover, randomized clinical trial. J Ren Nutr (2009) 1.09
Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy. J Lipid Res (2013) 1.09
Isolated soy protein consumption reduces urinary albumin excretion and improves the serum lipid profile in men with type 2 diabetes mellitus and nephropathy. J Nutr (2004) 1.09
Variations in isoflavone levels in soy foods and soy protein isolates and issues related to isoflavone databases and food labeling. J Agric Food Chem (2003) 1.07
Functions of TNF and its receptors in renal disease: distinct roles in inflammatory tissue injury and immune regulation. Semin Nephrol (2007) 1.07
Renal, metabolic and hormonal responses to ingestion of animal and vegetable proteins. Kidney Int (1990) 1.06
Inflammatory syndrome in chronic kidney disease: pathogenesis and influence on outcomes. Inflamm Allergy Drug Targets (2009) 1.05
Pharmacokinetics of the glucuronide and sulfate conjugates of genistein and daidzein in men and women after consumption of a soy beverage. Am J Clin Nutr (2002) 1.05
Lipids and diabetic nephropathy. Curr Diab Rep (2006) 1.05
Metabolic syndrome, components, and cardiovascular disease prevalence in chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Nephrol (2011) 1.05
Wnt/β-catenin signaling and kidney fibrosis. Kidney Int Suppl (2011) (2014) 1.01
Vegetarian diets and glycemic control in diabetes: a systematic review and meta-analysis. Cardiovasc Diagn Ther (2014) 1.00
Latest consensus and update on protein-energy wasting in chronic kidney disease. Curr Opin Clin Nutr Metab Care (2015) 1.00
Blockade of CCL2/CCR2 signalling ameliorates diabetic nephropathy in db/db mice. Nephrol Dial Transplant (2013) 0.99
Early chronic kidney disease: diagnosis, management and models of care. Nat Rev Nephrol (2015) 0.98
Effects of soy protein on renal function and proteinuria in patients with type 2 diabetes. Am J Clin Nutr (1998) 0.97
Soy isoflavone phase II metabolism differs between rodents and humans: implications for the effect on breast cancer risk. Am J Clin Nutr (2011) 0.97
Positive effect of dietary soy in ESRD patients with systemic inflammation--correlation between blood levels of the soy isoflavones and the acute-phase reactants. Nephrol Dial Transplant (2006) 0.96
Dietary composition and renal function in healthy subjects. Nephron (1987) 0.94
Soy protein modification of rat polycystic kidney disease. Am J Physiol (1998) 0.94
Protein digestibility-corrected amino acid scores (PDCAAS) for soy protein isolates and concentrate: criteria for evaluation. J Agric Food Chem (2011) 0.93
Dietary soy protein effects on disease and IGF-I in male and female Han:SPRD-cy rats. Kidney Int (2001) 0.93
Renal, metabolic, and hormonal responses to proteins of different origin in normotensive, nonproteinuric type I diabetic patients. Diabetes Care (1995) 0.93
Chronic kidney disease influences multiple systems: describing the relationship between oxidative stress, inflammation, kidney damage, and concomitant disease. Oxid Med Cell Longev (2015) 0.92
Controlled substitution of soy protein for meat protein: effects on calcium retention, bone, and cardiovascular health indices in postmenopausal women. J Clin Endocrinol Metab (2004) 0.90
Guidance from an NIH workshop on designing, implementing, and reporting clinical studies of soy interventions. J Nutr (2010) 0.90
Soy milk consumption, inflammation, coagulation, and oxidative stress among type 2 diabetic patients with nephropathy. Diabetes Care (2012) 0.90
Effect of dietary soy protein and genistein on disease progression in mice with polycystic kidney disease. Am J Kidney Dis (1998) 0.90
Diverse effects of increasing lisinopril doses on lipid abnormalities in chronic nephropathies. Circulation (2003) 0.90
Cellular oxidative processes in relation to renal disease. Am J Nephrol (2005) 0.90
Dietary soy protein effects on inherited polycystic kidney disease are influenced by gender and protein level. J Am Soc Nephrol (1999) 0.90
Health potential of soy isoflavones for menopausal women. Public Health Nutr (1999) 0.90
A soy protein diet alters hepatic lipid metabolism gene expression and reduces serum lipids and renal fibrogenic cytokines in rats with chronic nephrotic syndrome. J Nutr (2002) 0.89
KDOQI US commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD. Am J Kidney Dis (2014) 0.89
Peroxisomal proliferator-activated receptor-alpha protects renal tubular cells from doxorubicin-induced apoptosis. Mol Pharmacol (2007) 0.89
Hepatic gene expression following consumption of soy protein isolate in female Sprague-Dawley rats differs from that produced by 17{beta}-estradiol treatment. J Endocrinol (2009) 0.88
Lipid abnormalities in kidney disease and management strategies. World J Nephrol (2015) 0.88
Soy milk consumption and blood pressure among type 2 diabetic patients with nephropathy. J Ren Nutr (2013) 0.88
Lipid mediators in diabetic nephropathy. Fibrogenesis Tissue Repair (2014) 0.88
Renal protection by a soy diet in obese Zucker rats is associated with restoration of nitric oxide generation. Am J Physiol Renal Physiol (2004) 0.87
Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1995) 0.87
Management of diabetic renal disease. Ann Transl Med (2015) 0.87
Genistein modulates NF-κB-associated renal inflammation, fibrosis and podocyte abnormalities in fructose-fed rats. Eur J Pharmacol (2011) 0.86
Optimal nutrition for predialysis chronic kidney disease. Adv Chronic Kidney Dis (2013) 0.86
Soy protein diet ameliorates renal nitrotyrosine formation and chronic nephropathy induced by puromycin aminonucleoside. Life Sci (2004) 0.86
Beneficiary effect of dietary soy protein on lowering plasma levels of lipid and improving kidney function in type II diabetes with nephropathy. Eur J Clin Nutr (2003) 0.86
The role of soy in vegetarian diets. Nutrients (2010) 0.86
Modulation of age-related hyperparathyroidism and senile bone loss in Fischer rats by soy protein and food restriction. Endocrinology (1988) 0.86
Intradialytic protein supplementation reduces inflammation and improves physical function in maintenance hemodialysis patients. J Ren Nutr (2014) 0.85
Treatment of dyslipidemia in chronic kidney disease: Effectiveness and safety of statins. World J Nephrol (2012) 0.85
Soy protein and isoflavones influence adiposity and development of metabolic syndrome in the obese male ZDF rat. Ann Nutr Metab (2007) 0.85